DOI 10.3760/cma.j.cn112144-20260425-00259
[Role and mechanism of methyltransferase-like 3 in promoting macrophage NLRP3 inflammatory responses in medication-related osteonecrosis of the jaw].
Аннотация
Objective
To investigate the role and mechanism of methyltransferase-like 3 (METTL3) in regulating macrophage inflammatory responses and the development of medication-related osteonecrosis of the jaw (MRONJ) at the single-cell level.
Methods
Single-cell RNA sequencing was used to construct an immune atlas of zoledronic acid (ZA)-induced bisphosphonate-related osteonecrosis of the jaw(BRONJ)-like lesions in mice. Key epigenetic regulators were screened by bioinformatic analysis, and key genes were predicted using virtual knockdown analysis. METTL3 expression in vivo and in vitro was validated by immunohistochemical staining and Western blotting. In vitro knockdown and overexpression experiments were performed to clarify the regulatory effect of METTL3 on NLRP3 inflammasome activation in macrophages.
Results
The single-cell atlas showed that ZA treatment significantly induced the recruitment of specific pro-inflammatory macrophage subsets in extraction sockets, accompanied by marked activation of inflammation-related pathways. Bioinformatic screening indicated that NLRP3 inflammasome-related genes served as a central bridge linking inflammatory responses to RNA processing and modification. Pseudotime trajectory and virtual knockdown analyses further suggested that METTL3 functioned as a key node in maintaining the pro-inflammatory state of macrophages. In vivo and in vitro experiments confirmed that ZA significantly induced METTL3 upregulation at both tissue and cellular levels, accompanied by an increase in global m6A levels. Functional assays showed that METTL3 knockdown markedly suppressed NLRP3 inflammasome activation, whereas METTL3 overexpression exerted the opposite effect.
Conclusions
This study reveals the critical role of METTL3 as a positive regulator in promoting macrophage NLRP3 inflammatory responses in MRONJ pathogenesis. METTL3 is expected to provide clues for targeted therapy research on modulating local immune dysregulation and promoting bone repair in MRONJ.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.